{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T07:38:55Z","timestamp":1764401935755,"version":"build-2065373602"},"reference-count":14,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.intimp.2021.108136","type":"journal-article","created":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T22:29:36Z","timestamp":1631744976000},"page":"108136","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Adverse events occurring post-covid-19 vaccination among healthcare professionals \u2013 A mixed method study"],"prefix":"10.1016","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7773-5791","authenticated-orcid":false,"given":"Soumya","family":"Mahapatra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruchi","family":"Nagpal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"CM","family":"Marya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pratibha","family":"Taneja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sakshi","family":"Kataria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2021.108136_b0005","unstructured":"https:\/\/covid19.who.int\/. Accessed on date 28 July 2021."},{"key":"10.1016\/j.intimp.2021.108136_b0010","unstructured":"https:\/\/covid19.who.int\/table. Accessed on date 28 July 2021."},{"key":"10.1016\/j.intimp.2021.108136_b0015","doi-asserted-by":"crossref","first-page":"440","DOI":"10.51582\/interconf.7-8.04.2021.045","article-title":"Prospective sources of assistance to provide medical personnel with individual protection measures and covid-19 vaccination","volume":"21","author":"Chernenko","year":"2021","journal-title":"InterConf."},{"key":"10.1016\/j.intimp.2021.108136_b0020","doi-asserted-by":"crossref","unstructured":"S.C. Quinn, A.M. Jamison, V. Freimuth, Communicating effectively about emergency use authorization and vaccines in the COVID-19 pandemic, Am. J. Public Health 111, 355\u2013358. https:\/\/doi.org\/10.2105\/AJPH.2020.306036.","DOI":"10.2105\/AJPH.2020.306036"},{"key":"10.1016\/j.intimp.2021.108136_b0025","article-title":"Covid-19: India is at centre of global vaccine manufacturing, but opacity threatens public trust","volume":"372","author":"Thiagarajan","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.intimp.2021.108136_b0030","unstructured":"https:\/\/www.google.com\/search?q=covid+cases+in+april+2021+in+india&rlz=1C1EJFC_enIN902IN910&oq=covid+cases+in+april+2021+in+india&aqs=chrome..69i57j0i22i30l9.10805j0j7&sourceid=chrome&ie=UTF-8 and https:\/\/www.mygov.in\/covid-19. Accessed on date 28 July 2021."},{"key":"10.1016\/j.intimp.2021.108136_b0035","unstructured":"https:\/\/theprint.in\/health\/270-doctors-died-in-covid-second-wave-says-ima-number-would-be-higher-without-vaccines\/661789\/. Dasgupta S. 270 doctors died in Covid second wave, says IMA. Number would be higher without vaccines. The Print. 2021 May 20."},{"year":"2021","series-title":"AZD1222 vaccine against COVID-19 developed by Oxford University and Astra Zeneca: background paper: draft prepared by the Strategic Advisory Group of Experts (SAGE) on Immunization Working Group on COVID-19 vaccines, 10 February 2021","author":"World Health Organization","key":"10.1016\/j.intimp.2021.108136_b0040"},{"key":"10.1016\/j.intimp.2021.108136_b0045","unstructured":"WHO\u2019s Immunization in Practice, Module 3 entitled \u201cAdverse events following immunization\u201d. https:\/\/www.who.int\/vaccine_safety\/initiative\/tech_support\/Part-3.pdf?ua=1#:~:text=An%20Adverse%20event%20following%20immunization,laboratory%20finding%2C%20symptom%20or%20disease."},{"key":"10.1016\/j.intimp.2021.108136_b0050","unstructured":"WHO\u2019WHO\u2019s Adverse Events Following Immunization (AEFI). https:\/\/www.who.int\/teams\/regulation-prequalification\/regulation-and safety\/pharmacovigilance\/health-professionals-info\/aefi."},{"issue":"11","key":"10.1016\/j.intimp.2021.108136_b0055","first-page":"615","article-title":"Mandatory vaccination of health care workers: whose rights should come first?","volume":"34","author":"Field","year":"2009","journal-title":"Pharm. Therap."},{"issue":"7","key":"10.1016\/j.intimp.2021.108136_b0060","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.3390\/jcm10071428","article-title":"Prevalence of COVID-19 vaccine adverse events among healthcare workers in the Czech Republic","volume":"10","author":"Riad","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.intimp.2021.108136_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(21)00224-3","article-title":"Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study","author":"Menni","year":"2021","journal-title":"Lancet Infect. Dis."},{"issue":"1","key":"10.1016\/j.intimp.2021.108136_b0070","first-page":"1","article-title":"Age-associated changes in the impact of sex steroids on influenza vaccine responses in males and females","volume":"4","author":"Potluri","year":"2019","journal-title":"npj Vaccines."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576921007724?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576921007724?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:37:51Z","timestamp":1761586671000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576921007724"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":14,"alternative-id":["S1567576921007724"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2021.108136","relation":{},"ISSN":["1567-5769"],"issn-type":[{"type":"print","value":"1567-5769"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adverse events occurring post-covid-19 vaccination among healthcare professionals \u2013 A mixed method study","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2021.108136","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108136"}}